Combined effect of zoledronic acid and telomerase-specific oncolytic virotherapy for human osteosarcoma cells.

被引：1
|
作者：
Yamakawa, Yasuaki [1 ]
Hasei, Joe [1 ]
Tazawa, Hiroshi [2 ]
Osaki, Shuhei [1 ]
Sasaki, Tsuyoshi [1 ]
Kunisada, Toshiyuki [3 ]
Yoshida, Aki [1 ]
Urata, Yasuo [4 ]
Ozaki, Toshifumi [1 ]
Fujiwara, Toshiyoshi [5 ]
机构：
[1] Okayama Univ, Grad Sch, Dept Orthopaed Surg, Okayama 7008530, Japan
[2] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[3] Okayama Univ, Grad Sch, Dept Med Mat Musculoskeletal Reconstruct, Okayama 7008530, Japan
[4] Oncolys BioPharma Inc, Tokyo, Japan
[5] Okayama Univ, Grad Sch, Dept Gastroenterol Surg, Okayama 7008530, Japan
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3320
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination therapy of telomerase-specific oncolytic adenovirus and zoledronic acid in human osteosarcoma cells
    Yamakawa, Yasuaki
    Hasei, Joe
    Tazawa, Hiroshi
    Omori, Toshinori
    Osaki, Shuhei
    Sasaki, Tsuyoshi
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
    Guidong Li
    Hiroyuki Kawashima
    Akira Ogose
    Takashi Ariizumi
    Yongjun Xu
    Tetsuo Hotta
    Yasuo Urata
    Toshiyoshi Fujiwara
    Naoto Endo
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1037 - 1051
  • [3] Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
    Li, Guidong
    Kawashima, Hiroyuki
    Ogose, Akira
    Ariizumi, Takashi
    Xu, Yongjun
    Hotta, Tetsuo
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Endo, Naoto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 1037 - 1051
  • [4] Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma
    Li, Yue-Min
    Song, San-Tai
    Jiang, Ze-Fei
    Zhang, Qi
    Su, Chang-Qing
    Liao, Guo-Qing
    Qu, Yi-Mei
    Xie, Guo-Qing
    Li, Ming-Ying
    Ge, Fei-Jiao
    Qian, Qi-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (08) : 1274 - 1279
  • [5] Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer
    Fujiwara, Toshiyoshi
    Shirakawa, Yasuhiro
    Kagawa, Shunsuke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 525 - 532
  • [6] Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter
    Fujiwara, Toshiyoshi
    Urata, Yasuo
    Tanaka, Noriaki
    CURRENT CANCER DRUG TARGETS, 2007, 7 (02) : 191 - 201
  • [7] Telomerase-specific oncolytic virotherapy purging cancer stem cells
    Yano, Shuya
    Hashimoto, Yuuri
    Kuroda, Shinji
    Kojima, Tohru
    Uno, Futoshi
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Urata, Yasuo
    Tanaka, Noriaki
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2009, 69
  • [8] Telomerase-specific oncolytic virotherapy for humanhepatocellular carcinoma
    Yue-Min Li
    World Journal of Gastroenterology, 2008, (08) : 1274 - 1279
  • [9] Telomerase-specific oncolytic virotherapy promotes therapeuticefficacy of PD-1 blockade in murine osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
    Fujiwara, Toshiyoshi
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (09) : 1809 - 1816
12345